Skip to main content

VAN ECK ASSOCIATES CORP

Position in NVO — Novo Nordisk A S

CIK 869178 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$50,139,726
-$9,449,700 QoQ
Shares Held
1,045,885
-35.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. NVO ranks #10 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,139,726 1,045,885
2026-03-31 $59,589,426 1,621,481
2025-12-31 $83,705,181 1,645,149
2025-09-30 $43,766,183 788,722
2025-06-30 $46,146,426 668,595
2025-03-31 $31,078,358 447,557
2024-12-31 $39,825,969 462,985
2024-09-30 $58,638,045 492,467
2024-06-30 $61,068,739 427,832
2024-03-31 $52,374,488 407,901
2023-12-31 $33,594,042 324,737
2023-09-30 $24,852,628 273,286
2023-06-30 $19,343,701 119,531
2023-03-31 $22,894,516 143,864
2022-12-31 $31,488,475 232,662
2022-09-30 $26,171,705 262,689
2022-06-30 $28,807,997 258,530
2022-03-31 $18,988,106 170,987
2021-12-31 $17,488,576 156,148
2021-09-30 $15,845,106 165,036
2021-06-30 $11,855,130 141,520
2021-03-31 $10,889,745 161,521
2020-12-31 $12,522,428 179,276
2020-09-30 $12,305,981 177,243
2020-06-30 $10,444,780 159,511
2020-03-31 $9,672,394 160,671